Biological modifiers as potential radiosensitizers: Targeting the epidermal growth factor receptor family

Seminars in Oncology

Volumn 27, Issue 6 SUPPL. 11, 2000, Pages 15-20

  Sartor, C I ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; RADIOSENSITIZING AGENT;

CANCER RESISTANCE; CONFERENCE PAPER; EPITHELIUM TUMOR; GENE OVEREXPRESSION; GENE TARGETING; MULTIGENE FAMILY; PRIORITY JOURNAL; PROGNOSIS; RADIOSENSITIZATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BIOLOGICAL RESPONSE MODIFIERS; BREAST NEOPLASMS; CELL CYCLE; GENE EXPRESSION; GENES, ERBB-2; HEAD AND NECK NEOPLASMS; HUMANS; RADIATION-SENSITIZING AGENTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 0034471959     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (56)

1. Phase I study of concurrent radiation and twice-weekly gemcitabine in advanced pancreatic cancer
2. Gemcitabine-mediated radiosensitization
3. Taxanes as radiosensitizers for head and neck cancer
4. Concurrent paclitaxel and radiation therapy in the treatment of solid tumors
5. Monoclonal antibodies specific for the neu oncogene product directly mediate antitumor effects in vivo
6. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/ neu overexpressing human breast cancer xenografts
7. Addition of Herceptin to first line chemotherapy for HER2 overexpressing metastatic breast cancer markedly increases anticancer activity: A randomized, multinational controlled phase II trial
8. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers
9. Heterodimerization and functional interaction between EGF receptor family members: A new signaling paradigm with implications for breast cancer research
10. erbB-2 overexpression in human mammary epithelial cells confers growth factor independence
11. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells
12. Molecular themes in oncogenesis
13. The neuoncogene: Signal transduction pathways, transformation mechanisms and evolving therapies
14. Occurrence of microsatellite instability in gastric carcinoma is associated with enhanced expression of erbB-2 oncoprotein
15. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading
16. Expression of c-erbB-2 oncoprotein: A prognostic indicator in human breast cancer
17. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: Prognostic significance of erbB-2 protein overexpression in primary breast cancer
18. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer
19. erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer
20. Overexpression of both p185c-erbB2 and p170mdr-1 renders breast cancer cells highly resistant to Taxol
21. Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma
22. Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in vitro
23. Evaluation of HER-2/neu oncoprotein expression as a prognostic indicator of local recurrence in conservatively treated breast cancer: A case-control study
24. Monoclonal antibody to HER-2/neu receptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene
25. Calcium-dependent stimulation of mitogen-activated protein kinase activity in A431 cells by low doses of ionizing radiation
26. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation
27. The stress response to ionizing radiation involves c-Abl-dependent phosphorylation of SHPTP1
28. Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: Implications for human breast cancer
29. Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck
30. Rationale for combining EGF receptor blockade with radiation therapy for patients with advanced squamous cell carcinoma of the head and neck
31. Potentiation of radiation-induced breast cancer cell death by inhibition of epidermal growth factor family of receptors
32. Radiosensitization mediated by a transfected anti-erbB-2 single-chain antibody in vitro and in vivo
33. X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells
34. Radiosensitizing potential of gemcitabine (2′,2′-difluoro-2′-deoxycytidine) within the cell cycle in vitro
35. Chemoradiotherapy: Radiosensitizing nucleoside analogues
36. Cell cycle regulation in irradiated and nonirradiated cells
37. Radiosensitivity in ataxia-telangiectasia: Anomalies in radiation-induced cell cycle delay
38. Cell-cycle arrest versus cell death in cancer therapy
39. Defective G1-S cell cycle checkpoint function sensitizes cells to microtubule inhibitor-induced apoptosis
40. Role for c-Abl tyrosine kinase in growth arrest response to DNA damage
41. Hypersensitivity of ataxia telangiectasia fibroblasts to ionizing radiation is associated with a repair deficiency of DNA double-strand breaks
42. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
43. Defective control of apoptosis and mitotic spindle checkpoint in heterozygous carriers of ATM mutations
44. Correlation between gamma-ray-induced G2 arrest and radioresistance in two human cancer cells
45. Increased G2 delay in radiation-resistant cells obtained by transformation of primary rat embryo cells with the oncogenes H-ras and v-myc
46. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
47. Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway
48. PI3K: Downstream AKTion blocks apoptosis
49. Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells
50. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo
51. Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis
52. Conversion of a radioresistant phenotype to a more sensitive one by disabling erbB receptor signaling in human cancer cells
53. The effect of ionizing radiation on signal transduction: Antibodies to EGF receptor sensitize A431 cells to radiation
54. The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage
55. Radiosensitization of human tumor cell lines induced by the adenovirus-mediated expression of an anti-Ras single-chain antibody fragment
56. Phase I trial of chimerized anti-epidermal growth factor receptor antibody in combination with either once-daily or twice-daily irradiation for locally advanced head and neck malignancies